These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21571204)

  • 1. Blue toes after stimulant therapy for pediatric attention deficit hyperactivity disorder.
    Al Aboud A; Abrams M; Mancini AJ
    J Am Acad Dermatol; 2011 Jun; 64(6):1218-9. PubMed ID: 21571204
    [No Abstract]   [Full Text] [Related]  

  • 2. Attention-deficit/hyperactivity disorder stimulant medication reaction masquerading as chronic cough.
    Leibel S; Bloomberg G
    Ann Allergy Asthma Immunol; 2013 Aug; 111(2):82-3. PubMed ID: 23886223
    [No Abstract]   [Full Text] [Related]  

  • 3. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamines for attention-deficit/hyperactivity disorder in adults.
    Saguil A; Sheridan R
    Am Fam Physician; 2012 Sep; 86(5):413-5. PubMed ID: 22963059
    [No Abstract]   [Full Text] [Related]  

  • 6. Adderall and seizures.
    Thomas S; Upadhyaya H
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):365. PubMed ID: 11931590
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperactivity and hyperkinesis: another perspective.
    Calhoun G; Bolton J
    Adolescence; 1981; 16(63):685-7. PubMed ID: 7293853
    [No Abstract]   [Full Text] [Related]  

  • 8. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR; Smirnoff AV
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit/hyperactivity disorder: complexities and controversies.
    Schonwald A; Lechner E
    Curr Opin Pediatr; 2006 Apr; 18(2):189-95. PubMed ID: 16601502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of attention-deficit hyperactivity disorder.
    Taylor MA
    Am Fam Physician; 1997 Feb; 55(3):887-94, 897, 901 passim. PubMed ID: 9048509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECGs before stimulants in children.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):60. PubMed ID: 18654112
    [No Abstract]   [Full Text] [Related]  

  • 14. "Problem children' and stimulant drug treatment.
    Prior M
    Aust N Z J Psychiatry; 1981 Jun; 15(2):117-21. PubMed ID: 6945100
    [No Abstract]   [Full Text] [Related]  

  • 15. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of minimal brain dysfunction syndrome (clinical study using Captagon)].
    Mangold B
    Prax Kinderpsychol Kinderpsychiatr; 1975 Jul; 24(5):185-90. PubMed ID: 1187555
    [No Abstract]   [Full Text] [Related]  

  • 17. Adderall, the atypicals, and weight gain.
    Horrigan JP; Barnhill LJ; Kohli RR
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):620. PubMed ID: 11392337
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speed kills: amphetamines, children and nurses.
    Baldwin S
    Nurs Ethics; 2000 Nov; 7(6):535-7. PubMed ID: 11221396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.